Check the

PI2 HEALTH LIMITED

Company
PI2 HEALTH LIMITED (07078547)

PI2 HEALTH

Phone: 01271 336 200
A⁺ rating

ABOUT PI2 HEALTH LIMITED

We are expert providers of patient information leaflets (PILS) and user testing services to UK and global pharmaceutical clients.

The company was set up in 2005 by Julie Musk Managing Director who has a professional background in Speech and Language Therapy and has been producing patient information with the NHS, pharmaceutical companies and users for the past 15 years.

Our project team of plain English and information design specialists, usability experts, pharmacists and regulatory professionals offer a unique blend of skills to help you produce high quality information, usable medical devices and to ensure regulatory approval.

KEY FINANCES

Year
2017
Assets
£3.18k ▼ £-17.17k (-84.35 %)
Cash
£0k ▼ £-8.47k (-100.00 %)
Liabilities
£2.87k ▼ £-10.09k (-77.85 %)
Net Worth
£0.31k ▼ £-7.08k (-95.76 %)

REGISTRATION INFO

Company name
PI2 HEALTH LIMITED
Company number
07078547
Status
Active
Categroy
Private Limited Company
Date of Incorporation
17 Nov 2009
Age - 15 years
Home Country
United Kingdom

CONTACTS

Website
www.pi2health.com
Phones
01271 336 200
Registered Address
2 HASTINGS DRIVE,
CALNE,
WILTSHIRE,
SN11 8FS

ECONOMIC ACTIVITIES

73200
Market research and public opinion polling

LAST EVENTS

25 Nov 2016
Confirmation statement made on 17 November 2016 with updates
14 Oct 2016
Total exemption small company accounts made up to 31 March 2016
04 Jan 2016
Annual return made up to 17 November 2015 with full list of shareholders Statement of capital on 2016-01-04 GBP 1

See Also


Last update 2018

PI2 HEALTH LIMITED DIRECTORS

Julie Genet Musk

  Acting PSC
Appointed
17 November 2009
Occupation
Director
Role
Director
Age
62
Nationality
British
Address
2 Hastings Drive, Calne, Wiltshire, England, SN11 8FS
Country Of Residence
England
Name
MUSK, Julie Genet
Notified On
6 April 2016
Nature Of Control
Ownership of shares – 75% or more

REVIEWS


Check The Company
Excellent according to the company’s financial health.